Advertisement

Duration of Heart Failure, In-hospital Clinical Trajectory, and Post-discharge Outcomes Among Patients Hospitalized for Heart Failure

Published:November 06, 2022DOI:https://doi.org/10.1016/j.cardfail.2022.10.427
      Patients with long-standing chronic HF are at increased risk of death and hospitalization compared with HF patients more recently diagnosed.
      • Butt JH
      • Fosbøl EL
      • Gerds TA
      • Andersson C
      • McMurray JJ
      • Petrie MC
      • Gustafsson F
      • Madelaire C
      • Kristensen SL
      • Gislason GH.
      Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort.
      ,
      • Greene SJ
      • Hernandez AF
      • Dunning A
      • Ambrosy AP
      • Armstrong PW
      • Butler J
      • Cerbin LP
      • Coles A
      • Ezekowitz JA
      • Metra M.
      Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial.
      However, it remains unclear whether the overall clinical trajectory and in-hospital decongestion during hospitalization differs between patients with recently diagnosed versus worsening chronic HF (WCHF). We conducted a pooled, patient-level analysis of 3 HF clinical trials to characterize in-hospital decongestion and post-discharge outcomes among patients with recently diagnosed versus WCHF.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Butt JH
        • Fosbøl EL
        • Gerds TA
        • Andersson C
        • McMurray JJ
        • Petrie MC
        • Gustafsson F
        • Madelaire C
        • Kristensen SL
        • Gislason GH.
        Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort.
        European Journal of Heart Failure. 2020; 22: 1777-1785
        • Greene SJ
        • Hernandez AF
        • Dunning A
        • Ambrosy AP
        • Armstrong PW
        • Butler J
        • Cerbin LP
        • Coles A
        • Ezekowitz JA
        • Metra M.
        Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial.
        Journal of the American College of Cardiology. 2017; 69: 3029-3039
        • Felker GM
        • Lee KL
        • Bull DA
        • Redfield MM
        • Stevenson LW
        • Goldsmith SR
        • LeWinter MM
        • Deswal A
        • Rouleau JL
        • Ofili EO
        • Anstrom KJ
        • Hernandez AF
        • McNulty SE
        • Velazquez EJ
        • Kfoury AG
        • Chen HH
        • Givertz MM
        • Semigran MJ
        • Bart BA
        • Mascette AM
        • Braunwald E
        • CM O'Connor
        Diuretic strategies in patients with acute decompensated heart failure.
        New England Journal of Medicine. 2011; 364: 797-805
        • Bart BA
        • Goldsmith SR
        • Lee KL
        • Givertz MM
        • O'Connor CM
        • Bull DA
        • Redfield MM
        • Deswal A
        • Rouleau JL
        • LeWinter MM
        • Ofili EO
        • Stevenson LW
        • Semigran MJ
        • Felker GM
        • Chen HH
        • Hernandez AF
        • Anstrom KJ
        • McNulty SE
        • Velazquez EJ
        • Ibarra JC
        • Mascette AM
        • Braunwald E.
        Ultrafiltration in decompensated heart failure with cardiorenal syndrome.
        New England Journal of Medicine. 2012; 367: 2296-2304
        • Chen HH
        • Anstrom KJ
        • Givertz MM
        • Stevenson LW
        • Semigran MJ
        • Goldsmith SR
        • Bart BA
        • Bull DA
        • Stehlik J
        • LeWinter MM
        • Konstam MA
        • Huggins GS
        • Rouleau JL
        • O'Meara E
        • Tang WHW
        • Starling RC
        • Butler J
        • Deswal A
        • Felker GM
        • O'Connor CM
        • Bonita RE
        • Margulies KB
        • Cappola TP
        • Ofili EO
        • Mann DL
        • Dávila-Román VG
        • McNulty SE
        • Borlaug BA
        • Velazquez EJ
        • Lee KL
        • Shah MR
        • Hernandez AF
        • Braunwald E
        • Redfield MM
        Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
        Journal of the American Medical Association. 2013; 310: 2533-2543